Aaron J. Kowalski, Ph.D., CEO of Breakthrough T1D, spoke with Managed Healthcare Executive, talks about the possible impacts ...

The funding agency aims to cap “indirect costs” in biomedical research grants. But this behind-the-scenes work is crucial to making research happen.

Anglo American agrees sale of nickel business for up to $500 million Anglo American plc (‘Anglo American’) announces that it has entered into a definitive agreement to sell its nickel business to MMG ...